Adaptive Redox Homeostasis in Cutaneous Melanoma

Overview

Journal Redox Biol

Specialties Biology
Cell Biology
Endocrinology

Date 2020 Oct 22

PMID 33091721

Citations 34

Authors

Liaisan R Arslanbaeva

Massimo M Santoro

Affiliations

Soon will be listed here.

Abstract

Cutaneous melanoma is the most aggressive type of skin cancer. Although cutaneous melanoma accounts for a minority of all types of skin cancer, it causes the greatest number of skin cancer related deaths worldwide. Oxidative stress and redox homeostasis have been shown to be involved at each stage of a malignant melanocyte transformation, called melanomagenesis, as well as during drug resistance. Reactive oxygen species (ROS) play an important and diverse role that regulate many aspects of skin cell behaviors ranging from proliferation and stemness, to oxidative damage and cell death. On the other hand, antioxidants are associated with melanoma spread and metastasis. Overall, the contribution of redox homeostasis to melanoma development and progression is controversial and highly complex. The aim of this study is to examine the association between redox homeostasis and the melanomagenic process. To this purpose we are presenting what is currently known about the role of ROS in melanoma initiation and progression. In addition, we are discussing the role of antioxidant mechanisms during the spread of the disease and in cases of melanoma drug resistance. Although challenging, targeting redox homeostasis in melanoma progression remains to be a promising therapeutic approach, especially valid during melanoma drug resistance.

Citing Articles

Copper in melanoma: At the crossroad of protumorigenic and anticancer roles.

Chrzan N, Hartman M Redox Biol. 2025; 81:103552.

PMID: 39970778 PMC: 11880738. DOI: 10.1016/j.redox.2025.103552.

The Role of Glucose-6-Phosphate Dehydrogenase in Skin Cancer Metabolism: A Paradigm Shift in Treatment Approaches.

Abdullah A, Kumbrink J, Liokatis P, Mock A, Abdullah A, Dewenter I Cancers (Basel). 2025; 17(1.

PMID: 39796677 PMC: 11718909. DOI: 10.3390/cancers17010048.

Metabolic insights into tumor lymph node metastasis in melanoma.

Huang J, Gao Z, Xuan J, Gao N, Wei C, Gu J Cell Oncol (Dordr). 2024; 47(6):2099-2112.

PMID: 39704926 DOI: 10.1007/s13402-024-01027-4.

A Multifunctional Low-Temperature Photothermal Nanomedicine for Melanoma Treatment via the Oxidative Stress Pathway Therapy.

Zhang D, Liu X, Li X, Cai X, Diao Z, Qiu L Int J Nanomedicine. 2024; 19:11671-11688.

PMID: 39553457 PMC: 11566580. DOI: 10.2147/IJN.S487683.

Oxidative State in Cutaneous Melanoma Progression: A Question of Balance.

Benedusi M, Lee H, Lim Y, Valacchi G Antioxidants (Basel). 2024; 13(9).

PMID: 39334716 PMC: 11428248. DOI: 10.3390/antiox13091058.

References

Swope V, Abdel-Malek Z . MC1R: Front and Center in the Bright Side of Dark Eumelanin and DNA Repair. Int J Mol Sci. 2018; 19(9). PMC: 6163888. DOI: 10.3390/ijms19092667. View

Jeayeng S, Wongkajornsilp A, Slominski A, Jirawatnotai S, Sampattavanich S, Panich U . Nrf2 in keratinocytes modulates UVB-induced DNA damage and apoptosis in melanocytes through MAPK signaling. Free Radic Biol Med. 2017; 108:918-928. PMC: 5546090. DOI: 10.1016/j.freeradbiomed.2017.05.009. View

de Jager T, Cockrell A, Du Plessis S . Ultraviolet Light Induced Generation of Reactive Oxygen Species. Adv Exp Med Biol. 2017; 996:15-23. DOI: 10.1007/978-3-319-56017-5_2. View

Talebi A, Dehairs J, Rambow F, Rogiers A, Nittner D, Derua R . Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. Nat Commun. 2018; 9(1):2500. PMC: 6021375. DOI: 10.1038/s41467-018-04664-0. View

Pouli D, Balu M, Alonzo C, Liu Z, Quinn K, Rius-Diaz F . Imaging mitochondrial dynamics in human skin reveals depth-dependent hypoxia and malignant potential for diagnosis. Sci Transl Med. 2016; 8(367):367ra169. PMC: 5176339. DOI: 10.1126/scitranslmed.aag2202. View

Cai T, Kuang Y, Zhang C, Zhang Z, Chen L, Li B . Glucose-6-phosphate dehydrogenase and NADPH oxidase 4 control STAT3 activity in melanoma cells through a pathway involving reactive oxygen species, c-SRC and SHP2. Am J Cancer Res. 2015; 5(5):1610-20. PMC: 4497430. View

Espinosa-Diez C, Miguel V, Mennerich D, Kietzmann T, Sanchez-Perez P, Cadenas S . Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol. 2015; 6:183-197. PMC: 4534574. DOI: 10.1016/j.redox.2015.07.008. View

Sullivan M, Mattaini K, Dennstedt E, Nguyen A, Sivanand S, Reilly M . Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting. Cell Metab. 2019; 29(6):1410-1421.e4. PMC: 6551255. DOI: 10.1016/j.cmet.2019.02.015. View

Tetreault M, Yang Y, Katz J . Krüppel-like factors in cancer. Nat Rev Cancer. 2013; 13(10):701-13. DOI: 10.1038/nrc3582. View

10.

Liu Z, Pouli D, Alonzo C, Varone A, Karaliota S, Quinn K . Mapping metabolic changes by noninvasive, multiparametric, high-resolution imaging using endogenous contrast. Sci Adv. 2018; 4(3):eaap9302. PMC: 5846284. DOI: 10.1126/sciadv.aap9302. View

11.

Flaherty K, Puzanov I, Kim K, Ribas A, McArthur G, Sosman J . Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010; 363(9):809-19. PMC: 3724529. DOI: 10.1056/NEJMoa1002011. View

12.

Wu S, Naar A . SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait. Sci Rep. 2019; 9(1):10369. PMC: 6637239. DOI: 10.1038/s41598-019-46594-x. View

13.

Gorrini C, Harris I, Mak T . Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013; 12(12):931-47. DOI: 10.1038/nrd4002. View

14.

Park H, Carr J, Wang Z, Nogueira V, Hay N, Tyner A . FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J. 2009; 28(19):2908-18. PMC: 2760115. DOI: 10.1038/emboj.2009.239. View

15.

Ratnikov B, Scott D, Osterman A, Smith J, Ronai Z . Metabolic rewiring in melanoma. Oncogene. 2016; 36(2):147-157. PMC: 5140782. DOI: 10.1038/onc.2016.198. View

16.

Mugoni V, Postel R, Catanzaro V, De Luca E, Turco E, Digilio G . Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell. 2013; 152(3):504-18. PMC: 3574195. DOI: 10.1016/j.cell.2013.01.013. View

17.

Wang M, Shi G, Bian C, Nisar M, Guo Y, Wu Y . UVA Irradiation Enhances Brusatol-Mediated Inhibition of Melanoma Growth by Downregulation of the Nrf2-Mediated Antioxidant Response. Oxid Med Cell Longev. 2018; 2018:9742154. PMC: 5835260. DOI: 10.1155/2018/9742154. View

18.

Hu T, Zhang C, Tang Q, Su Y, Li B, Chen L . Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model. BMC Cancer. 2013; 13:251. PMC: 3765728. DOI: 10.1186/1471-2407-13-251. View

19.

Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann K, Speicher D . Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell. 2013; 23(6):811-25. PMC: 3810180. DOI: 10.1016/j.ccr.2013.05.003. View

20.

Baumler W, Regensburger J, Knak A, Felgentrager A, Maisch T . UVA and endogenous photosensitizers--the detection of singlet oxygen by its luminescence. Photochem Photobiol Sci. 2011; 11(1):107-17. DOI: 10.1039/c1pp05142c. View